|
1
|
Neely KA and Gardner TW: Ocular
neovascularization: clarifying complex interactions. Am J Pathol.
153:665–670. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chang JH, Garg NK, Lunde E, Han KY, Jain S
and Azar DT: Corneal neovascularization: An anti-VEGF therapy
review. Surv Opthalmol. 57:415–429. 2012. View Article : Google Scholar
|
|
3
|
Chan EC, van Wijngaarden P, Liu GS, Jiang
F, Peshavariya H and Dusting GJ: Involvement of Nox2 NADPH oxidase
in retinal neovascularization. Invest Ophthalmol Vis Sci.
54:7061–7067. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Engelmann D, Mayoli-Nüssle D, Mayrhofer C,
et al: E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis
in a feedback loop for cooperative induction of PDGF-B. J Mol Cell
Biol. 5:391–403. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ma JF, Von Kalle M, Plautz Q, Xu F-M,
Singh L and Wang L: Relaxin promotes in vitro tumour growth,
invasion and angio-genesis of human Saos-2 osteosarcoma cells by
AKT/VEGF pathway. Eur Rev Med Pharmacol Sci. 17:1345–1350.
2013.PubMed/NCBI
|
|
6
|
Muller YA, Christinger HW, Keyt BA and de
Vos AM: The crystal structure of vascular endothelial growth factor
(VEGF) refined to 1.93 A resolution: multiple copy flexibility and
receptor binding. Structure. 5:1325–1338. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ciulla TA, Danis RP, Criswell M and Pratt
LM: Changing therapeutic paradigms for exudative age-related
macular degeneration: antiangiogenic agents and photodynamic
therapy. Expert Opin Investig Drugs. 8:2173–2182. 1999. View Article : Google Scholar
|
|
8
|
Cheng SF, Dastjerdi MH, Ferrari G, et al:
Short-term topical bevacizumab in the treatment of stable corneal
neovascularization. Am J Ophthalmol. 154:940–948. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Campochiaro PA: Retinal and choroidal
neovascularization. J Cell Physiol. 184:301–310. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu XH, Kirschenbaum A, Yao S, et al:
Upregulation of vascular endothelial growth factor by cobalt
chloride-simulated hypoxia is mediated by persistent induction of
cyclooxygenase-2 in a metastatic human prostate cancer cell line.
Clin Exp Metastasis. 17:687–694. 1999. View Article : Google Scholar
|
|
11
|
Wang Y, Huang L, Yang Y, Xu L, Yang J and
Wu Y: Effects of autocrine vascular endothelial growth factor
(VEGF) in non-small cell lung cancer cell line A549. Mol Biol Rep.
40:3093–3099. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saint-Geniez M, Kurihara T, Sekiyama E,
Maldonado AE and D’Amore PA: An essential role for RPE-derived
soluble VEGF in the maintenance of the choriocapillaris. Proc Natl
Acad Sci USA. 106:18751–18756. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei L, Fraser JL, Lu ZY, Hu X and Yu SP:
Transplantation of hypoxia preconditioned bone marrow mesenchymal
stem cells enhances angiogenesis and neurogenesis after cerebral
ischemia in rats. Neurobiol Dis. 46:635–645. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Salcedo R, Wasserman K, Young HA, et al:
Vascular endothelial growth factor and basic fibroblast growth
factor induce expression of CXCR4 on human endothelial cells: In
vivo neovascularization induced by stromal-derived factor-1alpha.
Am J Pathol. 154:1125–1135. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin F, Brockmeier U, Otterbach F and
Metzen E: New insight into the SDF-1/CXCR4 axis in a breast
carcinoma model: hypoxia-induced endothelial SDF-1 and tumor cell
CXCR4 are required for tumor cell intravasation. Mol Cancer Res.
10:1021–1031. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ozcan Cenksoy P, Oktem M, Erdem O, et al:
A potential novel treatment strategy: Inhibition of angiogenesis
and inflammation by resveratrol for regression of endometriosis in
an experimental rat model. Gynecol Endocrinol. Nov 6–2014.Epub
ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li C, Wang L, Huang K and Zheng L:
Endoplasmic reticulum strss in retinal vascular degeneration:
Protective role of resveratrol. Invest Opthalmol Vis Sci.
53:3241–3249. 2012. View Article : Google Scholar
|
|
18
|
Jang M, Cai L, Udeani GO, et al: Cancer
chemopreventive activity of resveratrol, a natural product derived
from grapes. Science. 275:218–220. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
de la Lastra CA and Villegas I:
Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and
clinical implications. Biochem Soc Trans. 35:1156–1160. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Soufi FG, Mohammad-Nejad D and Ahmadieh H:
Resveratrol improves diabetic retinopathy possibly through
oxidative stress-nuclear factor κB-apoptosis pathway. Pharmacol
Rep. 64:1505–1514. 2012. View Article : Google Scholar
|
|
21
|
Huang W, Li G, Qiu J, Gonzalez P and
Challa P: Protective effects of resveratrol in experimental retinal
detachment. PLoS One. 8:e757352013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vin AP, Hu H, Zhai Y, et al:
Neuroprotective effect of resveratrol prophylaxis on experimental
retinal ischemic injury. Exp Eye Res. 108:72–75. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Busch F, Mobasheri A, Shayan P, Lueders C,
Stahlmann R and Shakibaei M: Resveratrol modulates
interleukin-1β-induced phosphatidylinositol 3-kinase and nuclear
factor κB signaling pathways in human tenocytes. J Biol Chem.
287:38050–38063. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang ZX, Wang YS, Shi YY, et al: Hypoxia
specific SDF-1 expression by retinal pigment epithelium initiates
bone marrow-derived cells to participate in Choroidal
neovascu-larization in a laser-induced mouse model. Curr Eye Res.
36:838–849. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Carbajo-Pescador S, Ordoñez R, Benet M, et
al: Inhibtion of VEGF expression through blockade of Hif1α and
STAT3 signalling mediates the anti-angiogenic effect of melatonin
in HepG2 liver cancer cells. Br J Cancer. 109:83–91. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Semenza GL: HIF-1 and mechanisms of
hypoxia sensing. Curr Opin Cell Biol. 13:167–171. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Piret JP, Mottet D, Raes M and Michiels C:
CoCl2V, a chemical inducer of hypoxia-inducible factor-1
and hypoxia reduce apoptotic cell death in hepatoma cell line
HepG2. Ann N Y Acad Sci. 973:443–447. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jin F, Hagemann N, Schäfer ST, Brockmeier
U, Zechariah A and Hermann DM: SDF-1 restores angiogenesis
synergistically with VEGF upon LDL exposure despite CXCR4
internalization and degradation. Cardiovasc Res. 100:481–491. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun X, Charbonneau C, Wei L, Yang W, Chen
Q and Terek RM: CXCR4-targeted therapy inhibits VEGF expression and
chon-drosarcoma angiogenesis and metastasis. Mol Cancer Ther.
12:1163–1170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Manu KA, Shanmugam MK, Rajendran P, et al:
Plumbagin inhibits invasion and migration of breast and gastric
cancer cells by downregulating the expression of chemokine receptor
CXCR4. Mol Cancer. 10:1072011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Manu KA, Shanmugam MK, Ramachandran L, et
al: First evidence that γ-tocotrienol inhibits the growth of human
gastric cancer and chemosensitizes it to capecitabine in a
xenograft mouse model through the modulation of NF-κB pathway. Clin
Cancer Res. 18:2220–2229. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shanmugam MK, Manu KA, Ong TH, et al:
Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to
suppression of metastasis in transgenic adenocarcinoma of mouse
prostate model. Int J Cancer. 129:1552–1563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang G, Chen C, Yang R, et al: p55PIK-PI3K
stimulates angiogenesis in colorectal cancer cell by activating
NF-κB pathway. Angiogenesis. 16:561–573. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Arora S, Bhardwaj A, Singh S, et al: An
undesired effect of chemotherapy: gemcitabine promotes pancreatic
cancer cell invasiveness through reactive oxygen species-dependent,
nuclear factor κB- and hypoxia-inducible factor 1α-mediated
up-regulation of CXCR4. J Biol Chem. 288:21197–21207. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Weekes CD, Song D, Arcaroli J, et al:
Stromal cell-derived factor 1α mediates resistance to mTOR-directed
therapy in pancreatic cancer. Neoplasia. 14:690–701. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kunimasa K, Ohta T, Tani H, et al:
Resveratrol derivative-rich melinjo (Gnetum gnemon L.) seed extract
suppresses multiple angiogenesis-related endothelial cell functions
and tumor angiogenesis. Mol Nutr Food Res. 55:1730–1734. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fouad MA, Agha AM, Merzabani MM and
Shouman SA: Resveratrol inhibits proliferation, angiogenesis and
induces apoptosis in colon cancer cells: calorie restriction is the
force to the cytotoxicity. Hum Exp Toxicol. 32:1067–1080. 2013.
View Article : Google Scholar : PubMed/NCBI
|
